LLY
Eli Lilly and Company
Eli Lilly and Company is a pharmaceutical firm with a dominant federal contract footprint ($3.29B) and direct executive branch holdings, but zero recent corporate insider buying.
Govt Dependence
85/100
Regulatory Density
95/100
Lobbying Intensity
5/100
Political Signal
NEUTRAL
BusinessWhat LLY does
Eli Lilly is a global pharmaceutical company that discovers, develops, and markets medicines across therapeutic areas including diabetes, oncology, neuroscience, and immunology. Its revenue is driven by biologic and small-molecule drug sales, with significant income from government healthcare programs and federal contracts. The company also engages in extensive payments to healthcare professionals for services like consulting and speaking.
12 months past · 3 months futureLLY activity timeline
Congress
buy
sell
Insider · Form 4
open-market buy
Hedge fund · 13F
opened
+ added
− trimmed
closed
holds
Bills
past action (this ticker)
upcoming markup (sector)
★ carveout (this ticker)
249 trading days ·
28 congressional trades shown
·
0 insider buys
·
7 13F filings
·
1 past bill actions
·
2 upcoming markups
Executive Branch ConflictsLLY held by Trump-administration officials
3 cabinet/senior officials reported LLY positions in OGE Form 278 disclosures across 35 filings.
Donald J. Trump
President · White House
ELI LILLY AND CO
Donald J. Trump
President · White House
ELI LILLY AND CO
Donald J. Trump
President · White House
ELI LILLY AND CO
Donald J. Trump
President · White House
Eli Lilly and Co
pharma
Donald J. Trump
President · White House
ELI LILLY AND CO
Donald J. Trump
President · White House
ELI LILLY AND CO
Donald J. Trump
President · White House
ELI LILLY AND CO
Donald J. Trump
President · White House
ELI LILLY AND CO
Donald J. Trump
President · White House
ELI LILLY AND CO
Donald J. Trump
President · White House
ELI LILLY AND CO
Donald J. Trump
President · White House
Eli Lilly and Co
pharma
Donald J. Trump
President · White House
ELI LILLY AND CO
Lifetime Government AwardsLLY federal contracts by year
$4.67B
total awarded · 2020–2026
7
contracts on file
2021
peak year ($1829M)
Top contracts by award amount
$1463.3M
Department of Defense
2022-02-10
LYCOV1404 BEBTELOVIMAB
$1373.9M
Department of Defense
2020-10-27
MONOCLONAL ANTIBODY LY-COV555
$1289.4M
Department of Defense
2021-11-01
PURCHASE OF A TOTAL OF 614,000 DOSES OF COMBINATION MONOCLONAL ANTIBOD
$329.8M
Department of Defense
2021-09-14
PURCHASE OF 388,000 DOSES OF MONOCLONAL ANTIBODY LY-COV016.
$210.0M
Department of Defense
2021-02-25
COMBINATION MONOCLONAL ANTIBODY - DELIVERY ORDER FOR 100,000 DOSES.
7 years · 7 contracts
Smart Money · 13F HoldingsHedge funds holding LLY
$148.82B
Total LLY held by tracked 13F funds
6
Funds with LLY positions
Renaissance Technologies
$66.03B
-57%
9 overlap
2026-03-31
Two Sigma Investments
$59.37B
+394%
9 overlap
2026-03-31
Soros Fund Management
$20.42B
holds
9 overlap
2026-03-31
Citadel Advisors
$2.40B
holds
14 overlap
2025-12-31
D.E. Shaw & Co.
$525M
-22%
14 overlap
2025-12-31
Bridgewater Associates
$79M
+602%
14 overlap
2025-12-31
Politicians Trading LLYMembers of Congress with recent LLY positions
23 politicians traded LLY across 126 disclosed transactions totaling $2.5M (last 730 days).
Greed score = composite of trade frequency, volume & recency across the politician's entire history (not just LLY). 0-30 LOW · 30-60 MID · 60+ HIGH.
Ashley Moody
2 buys
$350K
2025-03-06
LOW · 0
Jefferson Shreve
2 sells
$350K
2025-05-12
LOW · 0
Ron Wyden
2 buys
2 sells
$300K
2025-02-10
LOW · 0
Josh Gottheimer
2 buys
30 sells
$256K
2025-05-13
LOW · 1
Markwayne Mullin
3 buys
$183K
2025-12-29
LOW · 29
Jonathan L. Jackson
4 buys
4 sells
$162K
2025-06-03
LOW · 1
Ro Khanna
8 buys
7 sells
$145K
2026-06-02
LOW · 0
Gilbert Ray Cisneros
3 buys
3 sells
$115K
2026-06-10
HIGH · 61
David J. Taylor
5 buys
3 sells
$113K
2026-02-26
LOW · 10
Sheldon Whitehouse
2 buys
$65K
2024-10-30
LOW · 7
Greg Landsman
2 sells
$65K
2024-11-08
LOW · 0
Tommy Tuberville
2 sells
$65K
2025-04-15
LOW · 8
Lisa C. McClain
4 buys
4 sells
$64K
2025-07-16
LOW · 0
Julie Johnson
6 sells
$48K
2025-12-18
LOW · 15
Val T. Hoyle
2 buys
4 sells
$48K
2025-09-23
LOW · 0
8 more politicians active in LLY · full table in member dashboard
Congressional TradesWho in Congress is trading LLY
2026-07-10
Dan Newhouse
Sale
$1,001 - $15,000
2026-06-02
Ro Khanna
Purchase
$1,001 - $15,000
2026-06-10
Gilbert Ray Cisneros
Purchase
$50,001 - $100,000
2026-04-02
Byron Donalds
Purchase
$1,001 - $15,000
2026-04-14
Gilbert Ray Cisneros
Purchase
$1,001 - $15,000
2026-04-08
Lizzie Fletcher
Sale
$1,001 - $15,000
2026-03-13
Gilbert Ray Cisneros
Sale
$1,001 - $15,000
2026-02-13
Angus S. King
Sale (Full)
$1,001 - $15,000
2026-02-26
David J. Taylor
Purchase
$1,001 - $15,000
2026-02-09
David J. Taylor
Sale
$1,001 - $15,000
2026-01-23
Ro Khanna
Purchase
$1,001 - $15,000
2026-01-16
David J. Taylor
Sale
$1,001 - $15,000
30+ trades on file · most recent 2026-07-20
Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock
Stock awards & option exercises
10
stock awards · $71.6M market value
2026-02-17
LUCIANO JUAN R
Director
AWARD
15.363 sh
$16K
2026-02-17
Alvarez Ralph
Director
AWARD
11.985 sh
$12K
2026-02-17
Fyrwald J Erik
Director
AWARD
9.572 sh
$10K
2026-02-17
Sulzberger Gabrielle
Director
AWARD
4.786 sh
$5K
2026-02-09
Ricks David A
President, Chair, and CEO
AWARD
38,913.584 sh
$40.7M
2026-02-09
Skovronsky Daniel
EVP, CS&PO & Pres. LRL
AWARD
15,547.862 sh
$16.2M
2026-02-09
Van Naarden Jacob
EVP,Pres LLY Oncology&HdCorpBD
AWARD
4,865.888 sh
$5.1M
2026-02-09
Rau Diogo
EVP & CIDO
AWARD
4,432.32 sh
$4.6M
For LLY, executives receive stock primarily as compensation rather than via open-market purchases — typical for established large-cap firms.
Bills Affecting LLYLive legislation impacting this stock
HR.1860 · 119th
Women Veterans Cancer Care Coordination Act
HR.1867 · 119th
To amend title XVIII of the Social Security Act to remove in-person requirements under Medicare for mental health services furnish
HR.1843 · 119th
To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.
HRES.185 · 119th
Recognizing the need of Congress to prevent, address, and treat obesity as a disease in the United States on this World Obesity Da
HR.1784 · 119th
Medicare Fraud Detection and Deterrence Act of 2025
HR.1776 · 119th
New Health Options Act of 2025
HR.1775 · 119th
Second Chances for Rural Hospitals Act
HRES.182 · 119th
Expressing support for the designation of March 3, 2025, as "National Triple-Negative Breast Cancer Day".
S.786 · 119th
Public Health Funding Restoration Act
S.763 · 119th
Telehealth Expansion Act of 2025
Political ProfileWhere LLY sits in Washington
[object Object]
STRUCTURAL: Strong federal contract base ($3.29B from DoD/VA), executive branch holdings (Trump), and jurisdictional alignment with 8 politicians in `lobbying_patterns`. EVIDENTIARY: Zero corporate insider buys in 180 days (`get_corporate_insider_signal.total_buys: 0`), mixed congressional trading (15 trades, 7 purchases, 8 sales). Net: Structural support countered by lack of bullish insider or uniform political trading evidence.
Regulatory ExposureThreats & opportunities
Regulatory threats
-
High volume of healthcare sector legislation with revenue impact estimates.Congress"`bill_impacts` shows 8 recent healthcare bills with estimated revenue impacts ranging from $2.6M to $7.9M, though all have an impact_ratio of 0."
Regulatory opportunities
-
Jurisdictional alignment with key Senate committee members overseeing health policy.Congress"`get_political_influence.lobbying_patterns` shows 3 senators with committee jurisdiction over health (Wyden, Whitehouse, Tuberville) have lobbying event patterns matching LLY."
Capitol Hill AlliesChampions & critics
Congressional champions
Congressional critics
- No specific congressional critics identified.
LobbyingWho's hired to advocate for LLY
GRV STRATEGIES LLC defense
Member intelligence layer
Live signals + predictions for LLY — for Founders
The free page above gives you the public record. Members see the real-time intelligence layer on top of it:
- Live 7-layer signal scores when Congress trades LLY
- Bill Pass Index v2 odds for every bill on the watch list
- Iron Triangle alerts (committee × donor × trade)
- SEC Form 4 cluster detection (CEO + CFO + director buys)
- Whale-Opportunity expected-value ranking
- Custom watchlist alerts via email + Discord
Frequently AskedAbout LLY & political exposure
Does Eli Lilly and Company (LLY) hold federal contracts?
Yes. Eli Lilly and Company has 7 federal contract awards totaling $4,666,661,860, primarily from agencies including Department of Defense, Department of Veterans Affairs. See full contract list and amounts on this page.
Which Trump cabinet officials own LLY stock?
3 Trump cabinet members or senior White House staff have disclosed holdings in LLY on their OGE 278 financial disclosures, including Donald J. Trump, Lori Chavez-DeRemer, Sean Duffy. See the Cabinet Conflicts panel for details.
Has Congress traded LLY stock?
434 congressional trades by 50 unique members of Congress, most recently on 2026-07-10. See the Congressional Trading panel for politician-by-politician breakdown.
What is LLY political risk profile?
Government dependence: 85/100. Lobbying intensity: 5/100. Political signal: neutral. Donor party split: R 100% / D 0%.
How does GovGreed track LLY political activity?
GovGreed integrates STOCK Act congressional trade disclosures, FEC contributions, OGE executive-branch disclosures, USASpending federal contracts, Senate LDA lobbying filings, and SEC Form 4 corporate insider trades into a single queryable graph. LLY data is updated daily from these official federal sources.